Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sientra Inc    SIEN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/18/2017 09/19/2017 09/20/2017 09/21/2017 09/22/2017 Date
16.03(c) 15.56(c) 14.71(c) 14.67(c) 14.7(c) Last
409 866 335 838 229 359 174 240 82 667 Volume
+3.82% -2.93% -5.46% -0.27% +0.20% Change
More quotes
Financials ($)
Sales 2017 39,1 M
EBIT 2017 -53,7 M
Net income 2017 -58,6 M
Finance 2017 27,9 M
Yield 2017 -
Sales 2018 63,0 M
EBIT 2018 -46,8 M
Net income 2018 -47,0 M
Debt 2018 7,10 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 6,55x
EV / Sales2018 4,61x
Capitalization 284 M
More Financials
Company
Sientra, Inc. is a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices.Its products include breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders.The company was founded in 2006 by Hani M. Zeini... 
More about the company
Surperformance© ratings of Sientra Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on SIENTRA INC
09/16 SIENTRA : Industry Leaders Allergan and Sientra Invest in The American Society f..
08/16 SIENTRA : Houston Plastic Surgeon Offering Sientra Gummy Bear Breast Implants
08/09 SIENTRA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
08/09 SIENTRA : reports 2Q loss
08/09 SIENTRA, INC. : Results of Operations and Financial Condition, Financial Stateme..
08/09 SIENTRA, INC. (NASDAQ : SIEN) Files An 8-K Results of Operations and Financial C..
08/09 Sientra® Reports Second Quarter 2017 Financial Results
08/09 SIENTRA : Pledges Support as Platinum Sponsor of Plastic Surgery Meeting
08/02 SIENTRA : Announces Settlement of Lawsuit
08/01 SIENTRA, INC. : Other Events (form 8-K)
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/20 ESSILOR INTERNATIONAL : Luxottica, Essilor offer no merger concessions to EU reg..
09/19DJTEVA PHARMACEUTICAL INDUSTRIES : Sells Women's Health Assets -- WSJ
09/18DJTEVA PHARMACEUTICAL INDUSTRIES : Sells Slate of Women's Health Products in Debt-..
09/13 Apple suppliers dent European shares as rally flags
09/12DJMARKET SNAPSHOT : Stock Market Heads To Records As Investors Await Apple Device ..
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
09/19$SIEN ... Added last week to the AoT watchlist. Look at the 'ACCUMULATON VO..
4
09/15Industry Leaders Allergan and Sientra Invest in The American Society for Aest.. 
09/13Blair likes Sientra, upgrades to Outperform; shares ahead 16%  
09/13Sientra, Inc. $SIEN Receives Average Rating of “Buy” from Analysts  
09/13Sientra upgraded by William Blair to outperform.  
More tweets
Qtime:20
News from SeekingAlpha
09/13 Midday Gainers / Losers
09/13 Blair likes Sientra, upgrades to Outperform; shares ahead 16%
08/11 Sientra (SIEN) Presents At Canaccord Genuity 37th Annual Growth Conference - ..
08/09 Sientra's (SIEN) CEO Jeff Nugent on Q2 2017 Results - Earnings Call Transcrip..
08/09 Sientra misses by $0.48, beats on revenue
Chart SIENTRA INC
Duration : Period :
Sientra Inc Technical Analysis Chart | SIEN | US82621J1051 | 4-Traders
Technical analysis trends SIENTRA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 14,0 $
Spread / Average Target -4,8%
EPS Revisions
Managers
NameTitle
Jeffrey M. Nugent Chairman & Chief Executive Officer
Charles Huiner COO, SVP-Corporate Development & Strategy
Patrick F. Williams CFO, Treasurer & Principal Accounting Officer
Rosalyn Cole d’Incelli Vice President-Clinical Operations
Nicholas Simon Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SIENTRA INC72.65%284
MEDTRONIC PLC12.54%107 961
BAXTER INTERNATIONAL42.94%34 605
C R BARD INC41.27%23 155
ZIMMER BIOMET HOLDINGS INC9.55%23 131
HOYA CORPORATION23.29%21 111